Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prevention of Coronary Heart Disease in Morbidly Obese Patients (SphCor)
This study is currently recruiting participants.
Verified by The Hospital of Vestfold, February 2008
Sponsors and Collaborators: The Hospital of Vestfold
Rikshospitalet HF
Information provided by: The Hospital of Vestfold
ClinicalTrials.gov Identifier: NCT00626964
  Purpose

The changes in risks of developing coronary heart disease in morbidly obese patients after different weight loss interventions have not been extensively studied. The objective of this study is to investigate whether an intensive lifestyle intervention program in a tertiary care clinic (Spesialsykehuset for Rehabilitering) is comparable with bariatric surgery in decreasing the risk of cardiovascular disease in these patients.


Condition Intervention
Morbid Obesity
Hypertension
Type 2 DM
Obstructive Sleep Apnea
Osteoarthrosis
Procedure: Bariatric Surgery
Behavioral: Conservative Treatment:

MedlinePlus related topics: Coronary Artery Disease Heart Diseases High Blood Pressure Obesity Osteoarthritis Sleep Apnea Weight Control Weight Loss Surgery
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Prevention of Coronary Heart Disease in Morbidly Obese Patients. Lifestyle Intervention, Low Energy Diet or Bariatric Surgery.

Further study details as provided by The Hospital of Vestfold:

Primary Outcome Measures:
  • Arterial stiffness will decrease in the group with most weight loss [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Blood samples to biobank.


Estimated Enrollment: 200
Study Start Date: February 2008
Estimated Study Completion Date: January 2011
Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Morbidly Obesity with BMI > 40 kg/m2 or BMI > 35 with Comorbidity such as Hypertension, Type 2 Diabetes, Weight Related Osteoarthrosis, Obstructive Sleep Apnea
Procedure: Bariatric Surgery
Bariatric Surgery Treatment: Duodenal Switch, Gastric Sleeve or Gastric bypass.
Behavioral: Conservative Treatment:
Conservative Treatment: Intensive Lifestyle Intervention Program

Detailed Description:

Patients matching the eligibility criteria are divided into two groups (not randomized). One group will undergo 8 weeks preparation with Low Energy Diet before bariatric surgery, the other group will participate in an intensive lifestyle intervention program for 3 months.

Data on arterial stiffness, weight, body composition,blood samples, vital parameters are registered in the both groups at baseline, 7 weeks and after 1 year.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Morbidly Obese patients with BMI > 40, or BMI > 35 with comorbidity such as Hypertension, Obstructive Sleep Apnea, Weight Related Osteoarthrosis, Type 2 DM.

Criteria

Inclusion Criteria:

  • Morbidly Obese patients with BMI > 40, or BMI > 35 with comorbidity such as Hypertension, Obstructive Sleep Apnea, Weight Related Osteoarthrosis, Type 2 DM.

Exclusion Criteria:

  • Participation in other weight loss program the last 12 months. Serious psychiatric conditions
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00626964

Contacts
Contact: Jøran Hjelmeseth, Ph D 33342000 ext + 47 joran.hjelmeseth@siv.no
Contact: Khiem N-Dinh, MD 33342000 ext + 47 Khiem.N-Dinh@siv.no

Locations
Norway
Hospital of Vestfold Recruiting
Tønsberg, Norway, 3115
Contact: Jøran Hjelmeseth, Ph D     33342000 ext + 47     joran.hjelmeseth@siv.no    
Contact: Khiem N-Dinh, MD     33342000 ext + 47     Khiem.N-Dinh@siv.no    
Sponsors and Collaborators
The Hospital of Vestfold
Rikshospitalet HF
Investigators
Principal Investigator: Khiem N-Dinh, MD Center for Morbid Obesity, Vestfold Trust Hospital
  More Information

Responsible Party: The Hospital of Vestfold ( Jøran Hjelmesæth )
Study ID Numbers: S-0517
Study First Received: February 20, 2008
Last Updated: February 28, 2008
ClinicalTrials.gov Identifier: NCT00626964  
Health Authority: Norway: The National Committees for Research Ethics in Norway

Keywords provided by The Hospital of Vestfold:
Arterial stiffness
PulseWave velocity
Body composition
Inbody
Morbidly Obese
APO A
APO B
Framingham risk score
Prevention of Coronary Heart Disease
Morbidly Obese Patients
Lifestyle Intervention
Bariatric Surgery
Low Energy Diet

Study placed in the following topic categories:
Osteoarthritis
Myocardial Ischemia
Sleep Apnea, Obstructive
Sleep Disorders
Overweight
Arteriosclerosis
Sleep Disorders, Intrinsic
Body Weight
Signs and Symptoms
Respiratory Tract Diseases
Musculoskeletal Diseases
Arthritis
Nutrition Disorders
Arterial Occlusive Diseases
Obesity
Sleep Apnea Syndromes
Heart Diseases
Apnea
Joint Diseases
Respiration Disorders
Vascular Diseases
Dyssomnias
Obesity, Morbid
Ischemia
Rheumatic Diseases
Coronary Disease
Overnutrition
Coronary Artery Disease
Hypertension

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009